Modulation of oxidative stress response by flaxseed oil : Role of lipid peroxidation and underlying mechanisms

Copyright © 2018 Elsevier Inc. All rights reserved..

Polyunsaturated fatty acids (PUFA's) are majorly classified as ω-3 and ω-6 fatty acids. The eicosapentaenoic acid (EPA, ω-3:20-5), docosahexaenoic acid (DHA, ω-3:22-6) and alpha-linolenic acid (ALA, ω-3:18-3) are known ω-3 fatty acids, extracted from animal (e.g fish oil) and plant sources (e.g flaxseed oil). Furthermore, linoleic acid (LA, ω-6:18-2) is recognized as ω-6 fatty acid and the most prominent biological fatty acid with a pro-inflammatory response. Flaxseed oil has variety of biological roles, due to the significant amount of ω-3/ω-6 fatty acids. Numerous studies have reported that ALA (ω-3:18-3) and LA (ω-6:18-2) has diverse pharmacological activities. The ALA (ω-3:18-3) and LA (ω-6:18-2) are recognised to be the pharmacological antagonist. For example, ALA (ω-3:18-3) is recognised as anti-inflammatory, whereas LA (ω-6:18-2) is considered to be pro-inflammatory. PUFA's get oxidized in three ways; firstly, free radical-mediated pathway, secondly non-free radical non-enzymatic metabolism, and lastly enzymatic degradation. The present report is an attempt to summarize various modes of PUFA's metabolism and elaborate biological effects of the associated metabolites concerning flaxseed oil.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:135

Enthalten in:

Prostaglandins & other lipid mediators - 135(2018) vom: 15. März, Seite 21-26

Sprache:

Englisch

Beteiligte Personen:

Yadav, Rajnish Kumar [VerfasserIn]
Singh, Manjari [VerfasserIn]
Roy, Subhadeep [VerfasserIn]
Ansari, Mohd Nazam [VerfasserIn]
Saeedan, Abdulaziz S [VerfasserIn]
Kaithwas, Gaurav [VerfasserIn]

Links:

Volltext

Themen:

8001-26-1
Cancer
Enzymatic degradation
Fatty Acids, Omega-3
Fatty Acids, Omega-6
Inflammation
Journal Article
Linseed Oil
Lipid peroxidation
Polyunsaturated fatty acids
Research Support, Non-U.S. Gov't
Review

Anmerkungen:

Date Completed 07.01.2019

Date Revised 30.03.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.prostaglandins.2018.02.003

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM281108080